Over the past year, within retail pharmacy and IDNs, the U.S. hepatitis B market dose volume grew 23% year over year in Q3, while HEPLISAV-B dose volume grew 27%. These trends support our long-term ...
Q3 GDP-Adv. 2.8% (Briefing.com consensus 3.0%); Prior 3.0% ... Losses in Microsoft (MSFT) and Meta Platforms (META) weighed down the equity market after their earnings reports. Other mega caps ...